Cadonilimab Boosts Chemo in PD-L1-Negative Lung Cancer
In a groundbreaking development poised to reshape the therapeutic landscape for advanced non-small cell lung cancer (NSCLC), a recent phase II clinical trial reports remarkable results using cadonilimab in combination with chemotherapy...
Read moreDetails

